Absolute neutrophil count (ANC) >= 1,000/uL
Granulocytes >= 1,500/ul
Absolute neutrophil count (ANC) > 750/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute granulocytes >= 1500 cells/uL (1.5 x 10^9 L)
Peripheral absolute neutrophil count (ANC) >= 1,000/uL
Peripheral absolute neutrophil count (ANC) >= 750/uL
Absolute neutrophil count >= 1,000/uL (unsupported), within 14 days of registration and within 7 days of the start of treatment
Absolute neutrophil count (ANC) >= 1000/uL
CD4 count >= 50 cells/ul
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1,200/ul
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1500/ul
TUMOR BIOPSY SEQUENCING: Absolute neutrophil count >= 1,000/uL (mcL)
TREATMENT: Absolute neutrophil count >= 1,000/uL (mcL)
Absolute neutrophil count (ANC) >= 1000/ul (unsupported)
Absolute neutrophil count (ANC) >= 1500/uL
Absolute neutrophil count (ANC) >= 1000/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1500/uL; Note: no transfusions are permitted 7 days prior to laboratory studies to determine eligibility
Absolute neutrophil count (ANC) >= 1,200/ul
Granulocytes >= 1,500/ul
Absolute neutrophil count (ANC) >= 1,500/uL, obtained within 4 weeks prior to randomization
Absolute neutrophil count (ANC) >= 1,500/ul
Absolute neutrophil count (ANC) >= 1,500/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count >= 1000 cells/uL
INCLUSION CRITERIA FOR STRATUM C: Absolute neutrophil count >= 1000 cells/uL
Absolute neutrophil count >= 1,500/uL
Absolute neutrophil count > 1,500/uL
Absolute neutrophil count >= 1,500/uL
Absolute CD4 count > 200 cells/uL
Peripheral absolute neutrophil count (ANC) >= 750/uL
Absolute neutrophil count (ANC) > 1,500/uL
CD4+ T-cell count >= 100 cells/uL
Peripheral absolute neutrophil count (ANC) >= 1000/uL
Peripheral absolute neutrophil count (ANC) >= 1000/uL for patients with solid tumors without bone marrow involvement
Peripheral absolute neutrophil count (ANC) >= 750/uL for patients with solid tumors and known bone marrow metastatic disease
Absolute neutrophil count (ANC) >= 1500/uL
Absolute lymphocyte count (ALC) >= 800/uL
Absolute neutrophil count >= 1,500/uL